Thermo Fisher Scientific Inc/ US8835561023 /
| 9/22/2023 9:59:58 PM | Chg. +1.18 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 502.81USD | +0.24% | 51,913 Turnover: 26.18 mill. |
-Bid Size: - | -Ask Size: - | 194.05 bill.USD | 0.24% | 28.33 |
Fundamentals
| FY 2022 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 17.75 USD | -9.53% |
| EPS Diluted: | 17.63 USD | -9.40% |
| Revenues per Share: | 116.53 USD | 16.26% |
| Book Value per Share: | 114.24 USD | 9.39% |
| Cash Flow per Share: | 23.75 USD | -0.23% |
| Dividend per Share: | 1.20 USD | 15.38% |
| Total | in mill. | |
| Revenues: | 44,915.00 USD | 14.55% |
| Net Income: | 6,950.00 USD | -10.03% |
| Operating Cash Flow: | 9,154.00 USD | - |
| Cash and Cash Equivalents: | 8,524.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 28.33 | 31.02 |
| P/S Ratio: | 4.31 | 4.73 |
| P/BV ratio: | 4.40 | 4.82 |
| P/CF Ratio: | 21.17 | 23.19 |
| PEG: | -2.97 | -3.26 |
| Earnings Yield: | 3.53% | 3.22% |
| Dividend Yield: | 0.24% | 0.22% |
| Market Capitalization | ||
| Market Capitalization: | 194.05 bill. USD | 212.25 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 385.72 mill. | |
Profitability
| Gross Profit Margin: | - |
| EBIT Margin: | 18.69% |
| Net Profit Margin: | 15.47% |
| Return on Equity: | 15.78% |
| Return on Assets: | 7.15% |
Financial Strength
| Liquidity I / Cash Ratio: | 50.11% |
| Liquidity II / Quick Ratio: | 97.82% |
| Liquidity III / Current Ratio: | 148.32% |
| Debt / Equity Ratio: | 120.64% |
| Dynam. Debt / Equity Ratio: | 580.31% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 12/31/2022 |
| Accounting Standard: | US GAAP |
| Currency: | USD |